News
TyraTech announces global agreement for distribution of biocide products
14 August 2013
TyraTech (AIM: TYR and TYRU), a life sciences company focusing on natural insect and parasite control products, announces that it has entered into a global distribution partnership with a leading global Animal Health company to distribute a range of TyraTech's biocide products on a worldwide basis. These biocide products will be used in production animal facilities and premises to control flies, cockroaches and other insects.
The agreement with Novartis Animal Health, Inc. potentially enables a rapid, efficient route to market for some of TyraTech's animal health products. TyraTech's breakthrough technology provides a safe, effective, and environmentally-conscious solution to control insects in animal premises that cause both a health risk and significant economic losses to farmers.
This announcement is in line with TyraTech's previous announcement, dated 27 June 2013, where the Company disclosed discussions with major global animal health partners to commercialise some of its existing and pipeline products. TyraTech continues to pursue other opportunities with consumer products companies to market TyraTech's existing and future personal care products.
Commenting, Bruno Jactel, Chief Executive Officer of TyraTech said: "This agreement demonstrates the effectiveness and quality of our technology and product set. TyraTech has successfully developed and productised solutions to a number of significant worldwide problems for both animal and human health where no comparable solutions, in terms of efficacy and safety, currently exist. These problems represent multi-billion dollar markets in which TyraTech has the potential to be a significant player. We look forward to working with Novartis Animal Health and to seeing the biocide products successfully introduced to the market."
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| N+1 Singer, Nominated Adviser and Joint Broker Jonny Franklin-Adams / Alex Wright |
Tel: +44 20 7496 3000 |
| First Columbus LLP, Joint Broker Chris Crawford |
Tel: +44 20 3002 2070 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.